Vol 45: Considerations for Developing Pediatric Drug Products: A CMC Perspective
Considerations for Developing Pediatric Drug Products: A CMC Perspective
Vol 44: Reimagining Drug Development: Small Biotechs’ Strategies for Speed and Quality
Reimagining Drug Development: Small Biotechs’ Strategies for Speed and Quality
Vol 43: Challenges and Opportunities for Outsourcing CMC Development for Small Biotechs
Challenges and Opportunities for Outsourcing CMC Development for Small Biotechs
Vol 42: Key Analytical Tools for the Characterization of Drug Products in CMC Development
Key Analytical Tools for the Characterization of Drug Products in CMC Development
Vol 41: Implications of Recent Regulatory Changes on CMC Drug Development: A Look Ahead
Implications of Recent Regulatory Changes on CMC Drug Development: A Look Ahead
Vol 40: Best Practices for Setting Analytical Method Specifications
Optimizing Analytical Method Performance through Thoughtful Specification Setting
Vol 39: The Role of API Process Development in CMC Drug Development: A Comprehensive Overview
Optimizing the Drug Development Process: The Critical Importance of API Process Development
Vol 38: Get it Right the First Time: The Key to a Successful Regulatory Filing with Source Document Management and CTD Quality Module 3 Syncing
Streamlining Regulatory Compliance: Best Practices for Source Document Management and CTD Quality Module 3 Coordination
Vol 37: Unleash the Power of QbD: Transform Your Drug Product Development and Ensure Quality, Reliability, and Regulatory Approval
Revolutionizing Drug Product Development with Quality by Design (QbD) Principles
Vol 36: From Start to Finish: Managing Impurities and Degradants Throughout Drug Product Development
Controlling Impurities for Safe and Effective Drug Product Development